Synthetic lethality of PARP and NAMPT inhibition in triple‐negative breast cancer cells
Author:
Affiliation:
1. The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
2. Cancer Research UK Gene Function Laboratory, The Institute of Cancer Research, London, UK
Publisher
EMBO
Subject
Molecular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/emmm.201201250
Reference22 articles.
1. γH2AX and cancer
2. Ubiquitin Ligase RNF146 Regulates Tankyrase and Axin to Promote Wnt Signaling
3. Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699
4. Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma;Drevs J;Anticancer Res,2003
Cited by 104 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Regulation of CD73 on NAD metabolism: Unravelling the interplay between tumour immunity and tumour metabolism;Cell Communication and Signaling;2024-08-01
2. Targeting NAD Metabolism: Rational Design, Synthesis and In Vitro Evaluation of NAMPT/PARP1 Dual-Target Inhibitors as Anti-Breast Cancer Agents;Molecules;2024-06-14
3. Loss of cytidine deaminase expression as a potential attempt to counteract the process of carcinogenesis by reducing basal PARP-1 activity and increasing tau levels;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06
4. Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors;Molecular Cancer Therapeutics;2024-05-01
5. Activated NAD+ biosynthesis pathway induces olaparib resistance in BRCA1 knockout pancreatic cancer cells;PLOS ONE;2024-04-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3